Key result
Rapid-deployment aortic valve implantation in high-risk active endocarditis shows ~14% in-hospital mortality.
Why the study?
The potential benefits of rapid-deployment valve system in elderly high-risk patients with active infective endocarditis of the aortic valve were evaluated.
Is the rapid-deployment aortic valve system safe and feasible in elderly high-risk patients with active infective endocarditis of the aortic valve?
Observational (n=7)
No
Is the rapid-deployment aortic valve system safe and feasible in elderly high-risk patients with active infective endocarditis of the aortic valve?
The rapid-deployment aortic valve system appears to be a viable surgical option with acceptable morbidity and mortality for elderly, high-risk patients with active infective endocarditis.
Answers are grounded in this paper and cite their sources.
Should not yet change practice in aortic IE; hypothesis-generating for rapid-deployment valves in high-risk elderly patients.
Introduction The rapid-deployment valve system (RDVS) was introduced to facility minimally invasive aortic valve replacement. In this study we evaluate the potential benefits of RDVS in elderly high-risk patients with endocarditis of the aortic valve. Materials and Methods Since the introduction of RDVS in our institution in December 2017 through October 2021, EDWARDS INTUITY rapid-deployment prosthesis (Model 8300A, Edwards Lifesciences, Irvine, CA, USA) has been implanted in a total of 115 patients for different indications by a single surgeon. Out of one-hundred and fifteen cases of RDVS implantation, seven patients with a median age of 77 yrs. (range 62–84yrs.), suffered from active infective endocarditis of the aortic valve. The median EuroSCORE II of these highly selected patient cohort was 77% (range 19–80%). Patient data were evaluated perioperatively including intra-operative data as well as in-hospital morbidity/mortality and follow-up after discharge from hospital. Results Three patients underwent previous cardiac surgery. Concomitant procedures were performed in six patients including, ascending aorta replacement (n = 3), mitral valve repair (n = 1), pulmonary valve replacement (n = 1), bypass surgery (n = 1), left atrial appendix resection (n = 1) and anterior mitral valve repair (n = 1). Median aortic cross-clamp and cardiopulmonary bypass time was 56 min (range 29–122 min) and 81 min (range 45–162 min.), respectively. Post-operative complications in these elderly high-risk patients were atrial fibrillation (n = 3) and re-exploration for pericardial effusion (n = 1). One pacemaker implantation was required on postoperative day 6 due to sick sinus syndrome. There was one in-hospital death (14%) and one during follow-up (14%). Conclusion Rapid-deployment aortic valve system seems to be a viable option with acceptable morbidity and mortality in elderly high-risk patients with active infective endocarditis of the aortic valve.
No takes yet. Share an insight, caveat, or question.
Öner et al. (2022) conducted an observational in Active infective aortic valve endocarditis (n=7). Rapid-deployment aortic valve system (EDWARDS INTUITY) was evaluated on In-hospital mortality. Implantation of a rapid-deployment aortic valve system in elderly high-risk patients with active infective endocarditis resulted in one in-hospital death and one death during follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: